Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Aug;46(8):1036-1037.
doi: 10.1007/s00270-023-03487-x. Epub 2023 Jun 27.

Cost Matters: A Rigorous Economic Analysis of PAE with Comparison to TURP

Shamar Young  1
Affiliations
Editorial

Cost Matters: A Rigorous Economic Analysis of PAE with Comparison to TURP

Shamar Young. Cardiovasc Intervent Radiol. 2023 Aug.
No abstract available

PubMed Disclaimer

Comment on

References

    1. Capdevila F, Insausti I, San Miguel R, Sanchez-Iriso E, Montesino M. Cost-utility analysis of prostatic artery embolization for treatment of lower urinary tract symptoms. Cardiovasc Interv Radiol. 2023. https://doi.org/10.1007/s00270-023-03443-9 . (Epub ahed of print). - DOI
    1. Robinson R. Cost-utility analysis. BMJ. 1993;307(6908):859–62. - DOI - PubMed - PMC
    1. McDougall JA, Furnback WE, Wang BCM, Mahlich J. Understanding the global measurement of willingness to pay in health. J Mark Access Health Policy. 2020;8(1):1717030. - DOI - PubMed - PMC
    1. Rink JS, Froelich MF, McWilliams JP, Gratzke C, Huber T, Gresser E, et al. Prostatic artery embolization for treatment of lower urinary tract symptoms: a Markov model-based cost-effectiveness analysis. J Am Coll Radiol. 2022;19(6):733–43. - DOI - PubMed
    1. Wu X, Zhou A, Heller M, Kohlbrenner R. Prostatic artery embolization versus transurethral resection of the prostate for benign prostatic hyperplasia: a cost-effectiveness analysis. J Vasc Interv Radiol. 2022;33(12):1605–15. - DOI - PubMed

LinkOut - more resources